EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
2.160
-0.025 (-1.14%)
At close: May 14, 2025, 4:00 PM
2.180
+0.020 (0.93%)
After-hours: May 14, 2025, 4:00 PM EDT
EDAP TMS Market Cap
EDAP TMS has a market cap or net worth of $80.77 million as of May 14, 2025. Its market cap has decreased by -70.10% in one year.
Market Cap
80.77M
Enterprise Value
65.09M
1-Year Change
-70.10%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since December 31, 2001, EDAP TMS's market cap has increased from $17.50M to $80.77M, an increase of 361.53%. That is a compound annual growth rate of 6.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 13, 2025 | 81.70M | -0.73% |
Dec 31, 2024 | 82.30M | -57.88% |
Dec 29, 2023 | 195.40M | -45.60% |
Dec 30, 2022 | 359.20M | 86.11% |
Dec 31, 2021 | 193.00M | 28.07% |
Dec 31, 2020 | 150.70M | 17.28% |
Dec 31, 2019 | 128.50M | 139.74% |
Dec 31, 2018 | 53.60M | -34.95% |
Dec 29, 2017 | 82.40M | -1.08% |
Dec 30, 2016 | 83.30M | -18.89% |
Dec 31, 2015 | 102.70M | 102.17% |
Dec 31, 2014 | 50.80M | -6.27% |
Dec 31, 2013 | 54.20M | 99.26% |
Dec 31, 2012 | 27.20M | 23.64% |
Dec 30, 2011 | 22.00M | -64.23% |
Dec 31, 2010 | 61.50M | 132.95% |
Dec 31, 2009 | 26.40M | 100.00% |
Dec 31, 2008 | 13.20M | -68.79% |
Dec 31, 2007 | 42.30M | -7.44% |
Dec 29, 2006 | 45.70M | 4.10% |
Dec 30, 2005 | 43.90M | 48.31% |
Dec 31, 2004 | 29.60M | 112.95% |
Dec 31, 2003 | 13.90M | 49.46% |
Dec 31, 2002 | 9.30M | -46.86% |
Dec 31, 2001 | 17.50M | - |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 670.62B |
Johnson & Johnson | 357.23B |
AbbVie | 333.11B |
Novo Nordisk | 292.03B |
UnitedHealth Group | 289.91B |
Abbott Laboratories | 225.97B |
Novartis AG | 213.30B |
AstraZeneca | 210.42B |